Copyright
©The Author(s) 2015.
World J Diabetes. Feb 15, 2015; 6(1): 151-166
Published online Feb 15, 2015. doi: 10.4239/wjd.v6.i1.151
Published online Feb 15, 2015. doi: 10.4239/wjd.v6.i1.151
Microvascular complications prevalence | Macrovascular complications prevalence |
Retinopathy 23.7% | Cardiovascular disease 11.4% |
Background 20.0% | Peripheral vascular disease 4.0% |
Proliferative 3.7% | Cerebrovascular accidents 0.9% |
Nephropathy 5.5% | Hypertension 38.0% |
Peri-neuropathy 27.5% |
Ref. | Gene | SL No. | Location | Variation | SNP ID |
Blech et al[96] | PPARγ | 1 | Intron 1 | Pro12Ala | rs1801282 |
Blech et al[96]; Ramya et al[81] | ADIPOQ | 1 2 3 4 5 6 7 8 9 | 5’ flanking region Intron 1 Intron 1 Intron 1 Exon 1 coding synonymous Intron 1 Intron 1 5’ flanking region Exon 3 splicing enhancers | −11365 C/G -4522 C/T -3971 A/G +276 G/T +45 T/G +349 A/G +712 G/A -11391 G/A Y111H T/C | rs266729 rs822393 rs822396 rs1501299 rs2241766 rs2241767 rs3774261 rs17300539 rs17366743 |
Wang et al[97] | ADIPOR1 | 1 2 3 4 | Intron 1 Intron 1 Intron 1 5’ transcription factor binding site | +5646 A/G +5843 A/G -101 T/G -8503C/T | rs1342386 rs1342387 rs2275737 rs6666089 |
Vaxillaire et al[98] | ADIPOR2 | 1 2 3 4 5 6 | Exon 3 splicing enhancers Intron 1 5’ flanking region Intron 1 Intron 1 Intron 1 | +33371 C/T +26314 A/G -64241 T/G +8645 G/C +14645 A/T -35361 G/A | rs12342 rs767870 rs1029629 rs1468491 rs4766415 rs10773982 |
Thameem et al[99] | eNOS/NOS3 | 1 2 | Exon 3 splicing enhancers Intron 1 | Glu298Asp -786 T/C | rs1799983 rs2070744 |
Zhang et al[100] | NF-kB | 1 | 5’ flanking region | -94 insertion/deletion | rs28362491 |
Rees et al[101] | PEPCK | 1 | 5’ flanking region | -232C/G | rs2071023 |
Jang et al[82] and Ferreira et al[83] | Apolipoprotein A5 gene (APOA5) | 1 | 5’ flanking region | -1131T/C | rs662799 |
Ol et al[102] | COX-2 | 1 | 5’ flanking region | -765G/C | rs20417 |
Ho et al[103] | IL4 | 1 | 5’ flanking region | -590 C/T | rs2243250 |
- Citation: Ghoshal K, Bhattacharyya M. Adiponectin: Probe of the molecular paradigm associating diabetes and obesity. World J Diabetes 2015; 6(1): 151-166
- URL: https://www.wjgnet.com/1948-9358/full/v6/i1/151.htm
- DOI: https://dx.doi.org/10.4239/wjd.v6.i1.151